Roivant Sciences Ltd.
Financial highlights
| Metric | FY 03/31/26 | FY 03/31/25 | FY 03/31/24 | FY 03/31/23 | FY 03/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $<0.1 | $<0.1 | $<0.1 | $<0.1 | $0.1 |
| Operating income | -$0.5 | -$1.0 | $4.5 | -$0.9 | -$1.4 |
| Net income | -$0.3 | -$0.2 | $4.3 | -$1.0 | -$0.8 |
| Cash Flow Statement | |||||
| Free cash flow | -$0.8 | -$0.8 | -$0.8 | -$0.9 | -$0.7 |
| Share repurchases | — | $1.3 | $0.0 | $0.0 | $<0.1 |
Shares outstanding 722.3M · Free float 40.1%
Annual filing data through FY ended March 31, 2026; float as of September 11, 2026.